Why the study?
Is there a relationship between body mass index (BMI) and C-reactive protein (CRP) plasma levels in patients with polycystic ovarian syndrome (PCOS) compared to matched controls?
Population
40 patients with polycystic ovarian syndrome (PCOS) and 30 controls matched by age and BMI
Design
Case-control
Authors
Loading...
Elevated CRP in overweight PCOS may heighten CV risk awareness; observational data leaves causal mechanisms and interventions open for prospective study.
Is there a relationship between body mass index (BMI) and C-reactive protein (CRP) plasma levels in patients with polycystic ovarian syndrome (PCOS) compared to matched controls?
In patients with PCOS, elevated CRP levels are strongly driven by overweight status (BMI ≥ 25 kg/m²), highlighting the role of obesity in the inflammatory and cardiovascular risk profile of these patients.
Moradi et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: